Genetic and pharmacological manipulation of urotensin II ameliorate the metabolic and atherosclerosis sequalae in mice.

You, Zhipeng; Genest, Jacques; Barrette, Pierre-Olivier; Hafiane, Anouar; Behm, David J; D'Orleans-Juste, Pedro; Schwertani, Adel Giaid

You, Zhipeng; Genest, Jacques; Barrette, Pierre-Olivier; Hafiane, Anouar; Behm, David J; D'Orleans-Juste, Pedro; Schwertani, Adel Giaid.

Affiliation

You Z; Division of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.

Arterioscler Thromb Vasc Biol ; 32(8): 1809-16, 2012 Aug.

Article in En | MEDLINE | ID: mdl-22723440

Subject(s)

Atherosclerosis/etiology; Urotensins/physiology; Animals; Apolipoproteins E/physiology; Atherosclerosis/prevention & control; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Sulfonamides/pharmacology; Urotensins/blood

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Urotensins / Atherosclerosis Limits: Animals Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Urotensins / Atherosclerosis Limits: Animals Language: En Year: 2012 Type: Article